| Brian Kent Heaberlin, MD | |
|
146 E Hospital Dr Ste 200, West Columbia, SC 29169-4800 | |
| (803) 936-7530 | |
| (803) 936-7532 |
| Full Name | Brian Kent Heaberlin |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 23 Years |
| Location | 146 E Hospital Dr Ste 200, West Columbia, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992730493 | NPI | - | NPPES |
| 3810005836 | Medicaid | WV | |
| 2442280 | Medicaid | OH | |
| P00335936 | Other | RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0007X | Otolaryngology - Plastic Surgery Within The Head & Neck | TMP - 01602 (West Virginia) | Secondary |
| 207Y00000X | Otolaryngology | 52550 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lexington Medical Center | West columbia, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lexington Health Inc | 2567872070 | 753 |
News Archive
People with lactose intolerance are at lower risk of suffering from lung, breast and ovarian cancers, according to a new study by researchers at Lund University and Region Skåne in Sweden.
New findings suggest that American adults who survive deliberate self-harm are at increased risk of suicide in the first year after such an event, indicating a need to direct clinical interventions in the critical 12 months following such episodes.
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced 10 new or updated software packages to help customers harness the power of its new-generation liquid chromatography-mass spectrometry (LC-MS) instruments and turn data into knowledge in a wide range of discovery and quantitation experiments.
The Network for Excellence in Neuroscience Clinical Trials, or NeuroNEXT, a research program that helps streamline Phase II clinical trials for brain disorders, has been renewed for five more years, with several new centers joining the program
› Verified 9 days ago
| Entity Name | Lexington Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710634753 PECOS PAC ID: 2567872070 Enrollment ID: O20201208000922 |
News Archive
People with lactose intolerance are at lower risk of suffering from lung, breast and ovarian cancers, according to a new study by researchers at Lund University and Region Skåne in Sweden.
New findings suggest that American adults who survive deliberate self-harm are at increased risk of suicide in the first year after such an event, indicating a need to direct clinical interventions in the critical 12 months following such episodes.
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced 10 new or updated software packages to help customers harness the power of its new-generation liquid chromatography-mass spectrometry (LC-MS) instruments and turn data into knowledge in a wide range of discovery and quantitation experiments.
The Network for Excellence in Neuroscience Clinical Trials, or NeuroNEXT, a research program that helps streamline Phase II clinical trials for brain disorders, has been renewed for five more years, with several new centers joining the program
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian Kent Heaberlin, MD Po Box 6069, West Columbia, SC 29171-6069 Ph: () - | Brian Kent Heaberlin, MD 146 E Hospital Dr Ste 200, West Columbia, SC 29169-4800 Ph: (803) 936-7530 |
News Archive
People with lactose intolerance are at lower risk of suffering from lung, breast and ovarian cancers, according to a new study by researchers at Lund University and Region Skåne in Sweden.
New findings suggest that American adults who survive deliberate self-harm are at increased risk of suicide in the first year after such an event, indicating a need to direct clinical interventions in the critical 12 months following such episodes.
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced 10 new or updated software packages to help customers harness the power of its new-generation liquid chromatography-mass spectrometry (LC-MS) instruments and turn data into knowledge in a wide range of discovery and quantitation experiments.
The Network for Excellence in Neuroscience Clinical Trials, or NeuroNEXT, a research program that helps streamline Phase II clinical trials for brain disorders, has been renewed for five more years, with several new centers joining the program
› Verified 9 days ago
Dr. William Michael Greene, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 146 E Hospital Dr Ste 200, West Columbia, SC 29169 Phone: 803-936-7530 Fax: 803-936-7532 | |
Robert Osborne Brown Iii, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 146 E Hospital Dr Ste 200, West Columbia, SC 29169 Phone: 803-936-7530 Fax: 803-936-7532 | |
Jordan W Rawl, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 146 E Hospital Dr Ste 200, West Columbia, SC 29169 Phone: 803-936-7530 Fax: 803-936-7532 | |
Edward A Woody, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 146 E Hospital Dr Ste 200, West Columbia, SC 29169 Phone: 803-936-7530 Fax: 803-936-7535 | |
Neal W Burkhalter, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 146 E Hospital Dr Ste 200, West Columbia, SC 29169 Phone: 803-936-7530 Fax: 803-936-7535 | |
Andrew P Battiata, MD, MS Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 146 E Hospital Dr Ste 200, West Columbia, SC 29169 Phone: 803-936-7530 Fax: 803-936-7535 | |
Joyce M Brackebusch, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 146 E Hospital Dr Ste 200, West Columbia, SC 29169 Phone: 803-936-7530 Fax: 803-936-7532 |